ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,093.23
0.32%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.055
0.01%
Brent Oil
82.765
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. GeneDx Holdings Corporation (WGS)

  7. GeneDx Holdings Corporation (WGS) ニュース

WGS GeneDx Holdings Corporation

19.66
0.16 (0.82%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
GeneDx Holdings Corporation WGS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.16 0.82% 19.66 08:08:44
始値 安値 高値 終値 前日終値
19.47 19.09 21.71 19.66 19.50
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3005:05GLOBEGeneDx Reports First Quarter 2024 Financial Results and..
2024/4/2321:30GLOBEGeneDx Announces Partnership with Komodo Health to Expand..
2024/4/0505:05GLOBEGeneDx to Report First Quarter 2024 Financial Results on..
2024/3/1421:30GLOBEGeneDx to Present Data at the 2024 American College of..
2024/3/0606:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2706:05GLOBEGeneDx to Participate in 44th Annual Cowen Health Care..
2024/2/2406:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2106:28EDGAR2Form 8-K - Current report
2024/2/2106:26GLOBEGeneDx Reports Fourth Quarter and Full Year 2023 Financial..
2024/2/0206:30GLOBEGeneDx to Report Fourth Quarter 2023 Financial Results on..
2024/1/2506:30GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
2024/1/2406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0822:58EDGAR2Form 8-K - Current report
2024/1/0822:55GLOBEGeneDx Announces Preliminary 2023 Financial Results
2024/1/0507:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2011:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2011:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1306:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0606:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0122:30GLOBEGeneDx Presents New Data at the American Epilepsy Society..
2023/11/2906:05GLOBEGeneDx to Participate in 6th Annual Evercore ISI HealthCONx..
2023/11/2106:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
2023/11/1806:15EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/11/0405:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/3105:33EDGAR2Form 8-K - Current report
2023/10/3105:05GLOBEGeneDx Reports Third Quarter 2023 Financial Results and..
2023/10/2406:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1005:05GLOBEGeneDx to Report Third Quarter 2023 Financial Results on..
2023/10/0405:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2305:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
2023/9/2007:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2007:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1307:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1307:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1121:00GLOBEGeneDx Announces Evolution of Executive Leadership Team
2023/9/0705:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0621:00GLOBEGeneDx Announces Industry-Leading Accomplishment of 500,000..
2023/8/2120:00GLOBEGeneDx Announces Data Demonstrating that Whole Exome and..
2023/8/0909:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
2023/8/0905:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0905:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/8/0905:13EDGAR2Form 8-K - Current report
2023/8/0905:05GLOBEGeneDx Reports Second Quarter 2023 Financial Results and..
2023/8/0721:00GLOBEPacBio and GeneDx Launch Research Collaboration with the..
2023/7/2805:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2506:04EDGAR2Form 8-K - Current report
2023/7/2210:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1920:05GLOBEGeneDx and Prognos Health Announce Strategic Partnership to..

最近閲覧した銘柄

NASDAQ
WGS
GeneDx
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有